160 related articles for article (PubMed ID: 24771612)
21. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
[TBL] [Abstract][Full Text] [Related]
22. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
23. Cellular transcriptomics: gelsolin negatively regulates the expression of apoptosis-associated genes and inhibits apoptosis in hepatocarcinoma cells.
Zhou Y; Deng X; Ma X; Zang N; Li H; Li G; Li D; Li C; Huang W; He M
Int J Clin Exp Pathol; 2015; 8(11):13871-85. PubMed ID: 26823700
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia Augments Increased HIF-1α and Reduced Survival Protein p-Akt in Gelsolin (GSN)-Dependent Cardiomyoblast Cell Apoptosis.
Yeh YL; Hu WS; Ting WJ; Shen CY; Hsu HH; Chung LC; Tu CC; Chang SH; Day CH; Tsai Y; Huang CY
Cell Biochem Biophys; 2016 Jun; 74(2):221-8. PubMed ID: 27193608
[TBL] [Abstract][Full Text] [Related]
25. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
26. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
[TBL] [Abstract][Full Text] [Related]
27. Targeting X chromosome-linked inhibitor of apoptosis protein in mucoepidermoid carcinoma of the head and neck: A novel therapeutic strategy using nitidine chloride.
Kwon HJ; Yoon K; Jung JY; Ryu MH; Kim SH; Yoo ES; Choi SY; Yang IH; Hong SD; Shin JA; Cho SD
J Mol Med (Berl); 2020 Nov; 98(11):1591-1602. PubMed ID: 32901343
[TBL] [Abstract][Full Text] [Related]
28. Gelsolin knockdown confers radiosensitivity to glioblastoma cells.
Gao D; Jiang T; Liu Y
Cancer Med; 2024 May; 13(10):e7286. PubMed ID: 38803199
[TBL] [Abstract][Full Text] [Related]
29. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
Gagnon V; Van Themsche C; Turner S; Leblanc V; Asselin E
Apoptosis; 2008 Feb; 13(2):259-71. PubMed ID: 18071906
[TBL] [Abstract][Full Text] [Related]
30. The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance.
Asare-Werehene M; Nakka K; Reunov A; Chiu CT; Lee WT; Abedini MR; Wang PW; Shieh DB; Dilworth FJ; Carmona E; Le T; Mes-Masson AM; Burger D; Tsang BK
Oncogene; 2020 Feb; 39(7):1600-1616. PubMed ID: 31700155
[TBL] [Abstract][Full Text] [Related]
31. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
[TBL] [Abstract][Full Text] [Related]
32. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.
Li J; Feng Q; Kim JM; Schneiderman D; Liston P; Li M; Vanderhyden B; Faught W; Fung MF; Senterman M; Korneluk RG; Tsang BK
Endocrinology; 2001 Jan; 142(1):370-80. PubMed ID: 11145600
[TBL] [Abstract][Full Text] [Related]
33. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.
Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF
Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225
[TBL] [Abstract][Full Text] [Related]
34. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance.
Onuma T; Asare-Werehene M; Yoshida Y; Tsang BK
Cells; 2022 Oct; 11(20):. PubMed ID: 36291171
[TBL] [Abstract][Full Text] [Related]
35. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
Kim EH; Jang H; Roh JL
Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin induces apoptosis of hepatocellular carcinoma LM3 cells via down-regulation of XIAP.
Shang MJ; Hong DF; Hu ZM; Zhang CW; Wu WD
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):382-387. PubMed ID: 29424923
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
40. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]